Cargando…
Acute Hypersensitivity Reaction After Casirivimab/Imdevimab Infusion in a COVID-19-Positive Young Male: Myopericarditis or Kounis Syndrome?
Myocarditis has been a rare, but well-documented side effect of the mRNA-based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as a complication of viral infections including SARS-CoV-2. However, myopericarditis as a complication of monoclonal antibody infusion...
Autores principales: | Rivera, Jose A, Aragon, Daniel, Gomez, Jose, Arredondo, Hector, Thomas, Percy M, Dominici, Paul, Akala, Olabiyi O, Menowsky, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636892/ https://www.ncbi.nlm.nih.gov/pubmed/36382314 http://dx.doi.org/10.7759/cureus.31125 |
Ejemplares similares
-
RUSHing to the Diagnosis: Aortic Abdominal Aneurysm Detected Using the Rapid Ultrasound for Shock and Hypotension (RUSH) Protocol in the Wards
por: Rivera, Jose A, et al.
Publicado: (2022) -
Casirivimab/Imdevimab: First Approval
por: Deeks, Emma D.
Publicado: (2021) -
Casirivimab and imdevimab for COVID-19
Publicado: (2022) -
Bitten to the Bone: A Case of Anxiety-Induced Osteomyelitis
por: Rivera, Jose A, et al.
Publicado: (2022) -
Casirivimab/imdevimab: Lack of efficacy: case report
Publicado: (2022)